Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Outbreak of pre- and extensively drug-resistant tuberculosis in northern Italy: urgency of cross-border, multidimensional, surveillance systems.
Villa S, Tagliani E, Borroni E, Castellotti PF, Ferrarese M, Ghodousi A, Lamberti A, Senatore S, Faccini M, Cirillo DM, Codecasa LR. Villa S, et al. Among authors: ghodousi a. Eur Respir J. 2021 Sep 16;58(3):2100839. doi: 10.1183/13993003.00839-2021. Print 2021 Sep. Eur Respir J. 2021. PMID: 34049944 Free article. No abstract available.
Countrywide implementation of whole genome sequencing: an opportunity to improve tuberculosis management, surveillance and contact tracing in low incidence countries.
Cabibbe AM, Trovato A, De Filippo MR, Ghodousi A, Rindi L, Garzelli C, Baretti S, Allodi G, Mannino R, Rossolini GM, Bartoloni A, Tortoli E, Cirillo DM. Cabibbe AM, et al. Among authors: ghodousi a. Eur Respir J. 2018 Jun 28;51(6):1800387. doi: 10.1183/13993003.00387-2018. Print 2018 Jun. Eur Respir J. 2018. PMID: 29650560 Free article. No abstract available.
Clofazimine: A useful antibiotic for drug-resistant tuberculosis.
Mirnejad R, Asadi A, Khoshnood S, Mirzaei H, Heidary M, Fattorini L, Ghodousi A, Darban-Sarokhalil D. Mirnejad R, et al. Among authors: ghodousi a. Biomed Pharmacother. 2018 Sep;105:1353-1359. doi: 10.1016/j.biopha.2018.06.023. Epub 2018 Jun 29. Biomed Pharmacother. 2018. PMID: 30021373 Review.
Whole genome sequencing in Mycobacterium tuberculosis.
Spitaleri A, Ghodousi A, Miotto P, Cirillo DM. Spitaleri A, et al. Among authors: ghodousi a. Ann Transl Med. 2019 Sep;7(Suppl 6):S197. doi: 10.21037/atm.2019.07.28. Ann Transl Med. 2019. PMID: 31656776 Free PMC article. No abstract available.
Whole Genome Sequencing Results Associated with Minimum Inhibitory Concentrations of 14 Anti-Tuberculosis Drugs among Rifampicin-Resistant Isolates of Mycobacterium Tuberculosis from Iran.
Kardan-Yamchi J, Kazemian H, Battaglia S, Abtahi H, Foroushani AR, Hamzelou G, Cirillo DM, Ghodousi A, Feizabadi MM. Kardan-Yamchi J, et al. Among authors: ghodousi a. J Clin Med. 2020 Feb 7;9(2):465. doi: 10.3390/jcm9020465. J Clin Med. 2020. PMID: 32046149 Free PMC article.
Assessment of the GenoType MTBDRsl VER 2.0 compared to the phenotypic drug susceptibility testing and whole genome sequencing for the rapid detection of resistance to fluoroquinolone and second-line injectable drugs among rifampicin-resistant Mycobacterium tuberculosis isolates.
Kardan-Yamchi J, Amini S, Hamzelou G, Rahimi Foroushani A, Ghodousi A, Cirillo DM, Feizabadi MM. Kardan-Yamchi J, et al. Among authors: ghodousi a. Arch Microbiol. 2021 Sep;203(7):3989-3996. doi: 10.1007/s00203-021-02387-3. Epub 2021 May 25. Arch Microbiol. 2021. PMID: 34032874
52 results